Previous Article | Next Article 
Journal of Clinical Microbiology, July 1998, p. 1846-1852, Vol. 36, No. 7
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Molecular Epidemiological Study of Nosocomial
Enterobacter aerogenes Isolates in a Belgian
Hospital
Sheikh
Jalaluddin,1,2
Jeanne-Marie
Devaster,1
Robert
Scheen,1
Michele
Gerard,3 and
Jean-Paul
Butzler1,2,*
Department of
Microbiology1 and
Infectious Diseases
Department,3 Saint-Pierre University
Hospital, and
Department of Molecular Microbiology, Free
University of Brussels,2 Brussels, Belgium
Received 6 January 1998/Returned for modification 8 February
1998/Accepted 16 March 1998
 |
ABSTRACT |
In 1995, the rate of isolation of Enterobacter
aerogenes in the Saint-Pierre University Hospital in Brussels,
Belgium, was higher than that in the preceding years. A total of 45 nosocomial E. aerogenes strains were collected from 33 patients of different units during that year, and they were isolated
from 19 respiratory specimens, 13 pus specimens, 7 blood specimens, 4 urinary specimens, 1 catheter specimen, and 1 heparin vial. The strains
were analyzed to determine their epidemiological relatedness and were
characterized by their antibiotic resistance pattern determination,
plasmid profiling, and genomic fingerprinting by macrorestriction
analysis with pulsed-field gel electrophoresis (PFGE). The majority of the strains (82%) were multiply resistant to different commonly used
antibiotics. Two major plasmid profiles were found: most strains (64%)
harbored two plasmids of different sizes, whereas the others (20%)
contained a single plasmid. PFGE with SpeI and/or XbaI restriction enzymes revealed that a single clone
(80%) was responsible for causing infections or colonizations
throughout the year, and this result was concordant with those obtained
by plasmid profiling, with slight variations. By comparing the results of these three methods, PFGE and plasmid profiling were found to be the
techniques best suited for investigating the epidemiological relatedness of E. aerogenes strains, and they are therefore
proposed as useful tools for the investigation of nosocomial outbreaks caused by this organism.
 |
INTRODUCTION |
The genus Enterobacter is
one of the members of the family Enterobacteriaceae and
consists of 13 species (8). Among them, Enterobacter
cloacae and Enterobacter aerogenes are the most
frequently isolated species, causing infections in hospitalized and
debilitated patients (10, 29). In recent years, E. aerogenes has emerged as an important nosocomial bacterial
pathogen (6, 20). The strains are usually characterized by
their high levels of resistance to ampicillin, amoxicillin-clavulanic
acid, and expanded-spectrum cephalosporins or imipenem (3, 14, 23,
25). E. aerogenes outbreaks are often found to occur
among intensive care unit (ICU) patients, and colonization usually
occurs in the respiratory, urinary, and gastrointestinal tracts and
less frequently in skin and surgical wounds (1, 5, 7, 11,
21).
Nosocomial bacterial infections are an important cause of morbidity and
mortality in both developing and developed countries. Transmission of
nosocomial outbreak-related bacteria may be effectively controlled by
taking appropriate control measures. Before that is done, however, it
may be necessary to identify a particular clone or clones of bacteria.
The recognition that a single clone is spreading a number of infections
is an essential early step in the investigation of a possible outbreak
in a hospital. To do that, epidemiological typing of the strains is
performed by using possible genotypic and phenotypic methods.
Phenotypic techniques are insufficient for discriminating different
isolates of Enterobacter spp. However, a number of
genotype-based techniques have been successfully applied for
demonstrating the differences between the strains (4, 11-13,
15). In 1995, the isolation rate of E. aerogenes in
the Saint-Pierre University Hospital was higher than those in the
preceding years and in the following year. To determine whether the
strains were epidemiologically linked, we analyzed them by using
biotyping, antibiotyping, plasmid profiling, and genomic fingerprinting
by macrorestriction analysis with pulsed-field gel electrophoresis
(PFGE).
(This work was presented in part at the 97th General Meeting of the
American Society for Microbiology, Miami Beach, Fla., 4 to 8 May 1997 [14a].)
 |
MATERIALS AND METHODS |
Bacterial strains: origin and identification.
The
Saint-Pierre University Hospital is a 450-bed teaching hospital located
in the center of Brussels, Belgium. It has two ICUs (internal medicine
and surgery) of 13 beds each and several departments. The 45 E. aerogenes strains were collected from 33 patients hospitalized in
different wards, and their hospital records were reviewed by two
investigators to confirm nosocomial acquisition according to the
criteria of the Centers for Disease Control and Prevention
(9). The strains were isolated from 19 (42.2%) respiratory specimens, 13 (28.9%) pus specimens, 7 (15.6%) blood specimens, 4 (8.9%) urinary specimens, 1 (2.2%) catheter specimen, and 1 (2.2%)
heparin vial specimen.
E. aerogenes isolates were primarily identified in the
microbiology laboratory by standard culture techniques (8).
Subsequently, the identities of the strains were confirmed by the BBL
crystal E/NF identification system (Becton Dickinson, Cockeysville,
Md.). This system provides the interpretation of the results of 30 different biochemical tests including a manual oxidase and indole
tests. It is more reliable and cost-effective, can be performed more quickly and simply, and is safer to use than other commercially available microbial identification systems described in several reports
(24, 28, 32).
Screening of environmental specimens.
Environmental
specimens were screened for E. aerogenes by culturing
premoistened swabs from the suspected surfaces and liquid samples
obtained from different environmental sources or devices. The samples
included swabs of the table surfaces near the infected or colonized
patients (n = 10), disinfectants when they were
available at the bedside of the patients from ICUs and geriatric units
(n = 7), humidifying cascades from the mechanical
ventilators of the patients admitted to the ICUs (n = 15), oxygen humidifier bottles for nebulizers (n = 5),
tap water and hot and cold water faucets (n = 5), and a
heparin vial used for one patient admitted to an ICU (n = 1). No specimens from the hands of the hospital personnel were
available.
Antibiotic susceptibility testing.
Antimicrobial
susceptibility testing was performed on Mueller-Hinton agar (Oxoid
Ltd., Hampshire, United Kingdom) medium by a tablet disk diffusion
method with Neo-sensitabs (Rosco Diagnostica, Taastrup, Denmark)
against a panel of 14 antimicrobial drugs. Neo-sensitabs are
produced according to the guidelines of the World Health Organization
(33) and are standardized according to the MIC breakpoints
recommended by the National Committee for Clinical Laboratory Standards
(22). The zone sizes were interpreted according to the
guidelines of the National Committee for Clinical Laboratory Standards
(22). The tablet disks contained the following antimicrobial
agents: ampicillin, gentamicin, co-trimoxazole, amoxicillin-clavulanic
acid, piperacillin-tazobactam, aztreonam, temocillin, ceftazidime,
cefazolin, cefuroxime, ceftriaxone, imipenem, ciprofloxacin, and
amikacin. Strains with intermediate zones were considered resistant.
Plasmid profile analysis.
Plasmid DNA of the 45 strains was
prepared by the method described by Portnoy et al. (26). By
this method, the lysis solution destroys the cell wall as well as the
cell membrane and denatures the chromosomal DNA in a single step by the
combined action of sodium dodecyl sulfate and an alkaline solution. The
technique is based on the fact that a narrow pH range (pH 12.00 to
12.55) can denature only the linear chromosomal DNA and not the
covalently closed circular plasmid DNA.
Plasmids were separated by electrophoresis run at 80 V for 4 h in
a 0.7% agarose gel containing 1× TBE (Tris-borate-EDTA) buffer. The
gels were stained in a 1-µg/ml ethidium bromide solution, visualized
under UV light, and photographed with a Polaroid camera. The sizes of
the plasmids were determined by using as a standard Escherichia
coli V517, which contains seven different plasmids (16).
DNA macrorestriction and PFGE.
Genomic DNA was prepared by a
protocol devised from different methods published elsewhere (2,
17, 19, 30). Bacterial cells were grown in 5.0 ml of Trypticase
soy broth at 37°C overnight in a shaking water bath with agitation,
and the optical density at 600 nm was measured. The optical density at
600 nm was adjusted with sterile Trypticase soy broth so that it had a
cell concentration of 109 CFU/ml. For each isolate, 100 µl of the cell suspension was pelleted by centrifugation and washed
with EET buffer (100 mM sodium EDTA, 10 mM sodium EGTA, 10 mM Tris-HCl
[pH 7.5]), and the pellet was resuspended in 100 µl of the same
buffer, an equal volume of 2% melted InCert agarose (FMC Bio Products,
Vallensbaek Strand, Denmark) was mixed in, and the mixture was
dispensed into two wells of the plug mold. After solidification, the
plugs were incubated at 37°C for 1 h in 500 µl of lysis
solution (lysozyme, 1 mg/ml; Tris-HCl, 10 mM; NaCl, 50 mM; sodium
deoxycholate, 0.2%; sodium-N-lauroylsarcosine, 0.5%) and
washed once with T10E1 buffer (Tris-HCl, 10 mM;
sodium EDTA, 1 mM [pH 7.5]). The agarose plugs were subsequently
deproteinized in 500 µl of proteinase K solution (proteinase K, 1 mg/ml; EDTA, 100 mM [pH 8.0]; sodium deoxycholate, 0.2%;
sodium-N-lauroylsarcosine, 1%) at 50°C overnight, and the
protein digestion products were removed by washing the plugs six times
for 30 min each time with 1.0 ml of T10E1
buffer. During the second wash 15 µl of phenylmethylsulfonyl fluoride
(100 mM) was added to inactivate the residual proteinase K activity.
The
E. aerogenes plugs were digested with 25 U of
SpeI restriction enzyme, and a duplicate set of plugs was
also digested
with 40 U of
XbaI restriction enzyme according
to the manufacturer's
instructions. The resultant fragments were
resolved in the CHEF
DRII system (Bio-Rad, Nazareth, Belgium) with a
1% agarose gel
prepared and run in 0.5× TBE buffer. The gels were run
at 6 V/cm
for 20 h at 14°C. The pulse time ramped from 5 to
15 s for 20
h for
SpeI-restricted plugs and two
linear ramps of 5 to 40 s
for 12 h followed by 3 to 8 s
for 8 h for
XbaI-restricted plugs.
The PFGE marker-I
(Boehringer Mannheim, Brussels, Belgium) was
used as a molecular size
standard. The gels were stained with
ethidium bromide (1 µg/ml) and
photographed under UV light.
The PFGE patterns were compared initially by visual comparison and were
interpreted according to the guidelines of Tenover
et al.
(
31). Patterns were considered indistinguishable if every
band was shared, closely related if they differed from one another
by
only two or three clearly visible bands, and different if they
differed
by seven or more bands.
With the Molecular Analyst Software Fingerprinting, version 1.0 (Bio-Rad, Richmond, Calif.), PFGE patterns were also compared
and
clustered into a dendrogram.
 |
RESULTS |
Bacterial strains.
In this investigation, 45 E. aerogenes isolates originating from 33 hospitalized patients were
available. These patients represented 84.6% of the 39 hospitalized
patients from whom the organism was recovered in the year 1995. Single
isolates were obtained from 26 patients, two isolates were obtained
from 4 patients, three isolates were obtained from 2 patients, four
isolates were obtained from 1 patient, and one isolate was obtained
from a heparin vial specimen (Table 1).
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Phenotypic and genotypic characters of E. aerogenes isolates isolated from patients in Saint-Pierre
University Hospital in 1995a
|
|
Biotyping.
Fourteen different biotypes were generated among
the 45 E. aerogenes isolates on the basis of the formulated
profile found after positive and negative reactions in different wells
of the BBL crystal E/NF identification system. The biotypes were
arbitrarily designated 1 to 14. In a few patients the biotypes differed
among the strains according to the site of isolation (Table 1).
Screening of environmental specimens.
E. aerogenes was
isolated from the heparin vial specimen only. No E. aerogenes was found in any of the other environmental specimens.
Antibiotyping.
E. aerogenes isolates were grouped into
11 different antibiotypes depending upon their susceptibilities to 14 different antimicrobial drugs. Almost all strains were resistant to
ampicillin, cefazolin, and cefuroxime but were sensitive to gentamicin,
temocillin, amikacin, and imipenem. The antimicrobial resistance
patterns were pooled, and it was found that 91 to 100% of the strains
were resistant to ampicillin, cefazolin, and cefuroxime; 82 to 84%
were resistant to co-trimoxazole, aztreonam, ceftazidime, and
ciprofloxacin; 56% were resistant to ceftriaxone, 40% were resistant
to piperacillin-tazobactam; 31% were resistant to
amoxicillin-clavulanate; and 2% were resistant to temocillin. The
antibiotypes are presented in Table 1.
Plasmid profile analysis of E. aerogenes.
Plasmids
were found in 43 (96%) of the 45 E. aerogenes isolates.
Only one strain (from patient 29) harbored five plasmids of
different sizes, whereas the rest of the strains were grouped into
three different profiles depending upon the sizes and the numbers of
the plasmids.
Profile A consists of a big (30 to 40 MDa) and a small (5 to 6 MDa)
plasmid. A total of 29 (64%) strains belonged to this
profile. Ten
(22%) strains belonged to profile B, which contained
a single plasmid
of 5 to 6 MDa. Profile C was found for four strains
(9%), which
contained three plasmids (20 to 30, 15 to 20, and
5 to 6 MDa,
respectively). The plasmid data are listed in Table
1.
PFGE.
All 45 strains were typeable, and the fingerprints
generated with both SpeI and XbaI restriction
endonucleases equally demonstrated that 36 (80%) strains were derived
from a single clone, designated clone I. Six (13%) strains were
closely related and were designated as being derived from
clones IIa and IIb, and only three (7%) strains were found to be
nonclonal. The XbaI-digested fragments were more easily
interpretable than the SpeI-digested fragments (Fig.
1). The dendrogram generated from PFGE
patterns gave similar information (Fig.
2).

View larger version (175K):
[in this window]
[in a new window]
|
FIG. 1.
PFGE fingerprints of 45 E. aerogenes isolates
(1995) after digestion with the XbaI restriction enzyme (A)
and the SpeI restriction enzyme (B). Lane FH54 to lane BG64,
profile IA and profile IB (broadly clone I); lane FH51 to lane FH90,
profiles IIA, IIB, and IIC (broadly, clone II); lane FH49 to lane FH77,
unrelated strains (nonclonal); lanes M, molecular size markers (PFGE
marker I, ladder).
|
|

View larger version (8K):
[in this window]
[in a new window]
|
FIG. 2.
Dendrogram generated from PFGE patterns of nosocomial
E. aerogenes strains (n = 45) by Molecular
Analyst Software Fingerprinting, version 1.0. Major clones are
designated with arabic numerals, and subtypes are indicated by letter
suffixes. Clustering was done with the unweighted pair group method
with arithmatic averages algorithm by using fine correlation on gel
tracks.
|
|
Primary analysis of the clinical data from colonized and infected
patients.
The 45 E. aerogenes isolates were recovered
from 33 patients, of whom 22 (66.7%) were infected and 11 (33.3%)
were considered colonized. Most of the patients were elderly,
were suffering from chronic underlying diseases, and were hospitalized
in either the medical or the surgical ICU. During their
hospitalization, 13 patients died (crude mortality rate, 39%). The
clinical features are presented in Table
2.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Clinical features of the 33 patients infected or
colonized with E. aerogenes strains in Saint-Pierre
University Hospital in 1995
|
|
 |
DISCUSSION |
E. aerogenes is able to cause nosocomial infections,
like other members of the family Enterobacteriaceae. In
1995, the incidence of E. aerogenes in our hospital was
higher than those in the preceding and the following years (Fig.
3). Among the 33 patients, the ratio of
colonization and infection (1:2), as well as the high crude mortality
rate (39%) among the E. aerogenes-infected patients, led us
to be particularly concerned so we studied the epidemiology of this
bacterium. In our study, we found that E. aerogenes
colonizations or infections were endemic in the year 1995 and continued
to the following year (unpublished data). The first isolated strain
belonging to clone I (80% of the total isolates) appeared in January
and infected a 58-year-old patient in the geriatric unit. This patient was colonized after 8 days of hospitalization and developed pneumonia and subsequently a urinary tract infection. The second acquisition occurred in April and was of a nonclonal strain that infected a
70-year-old patient in the surgical ICU; the patient developed septicemia, followed by death. From July until December, we found a
real nosocomial outbreak caused by the two major clonal groups, groups
I and II (Table 2). Most of the acquisitions occurred among elderly
patients admitted to the two ICUs and the geriatric unit or transferred
among these units. In this period, patients were probably colonized or
infected through patient-to-patient transmission, via hospital
personnel, or from other unknown hospital devices or environmental
sources. The cause of the disappearance of the predominant clonal
strain (clone I) in the months of February until June is not known, but
infection control measures were probably strictly maintained at that
time.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 3.
Incidence of E. aerogenes at Saint-Pierre
University Hospital from January 1994 to December 1996.
|
|
We analyzed some environmental specimens (n = 43), but
only one E. aerogenes isolate was recovered from a
patient's heparin vial (strain 4 of patient 2) used for parenteral
treatment. The E. aerogenes isolate from this source did not
belong to the predominant clone I and had the same antibiotype, plasmid
profile, and PFGE pattern as those of two other blood isolates of the
same patient. This indicates that for this patient transmission
occurred through the heparin vial, which could possibly have been
contaminated by the hands of the hospital personnel.
Epidemiologic typing of the bacterial strains is being performed by
using phenotypic and genotypic techniques. Phenotypic techniques are
insufficient for discriminating among the isolates of different
Enterobacter spp. In the present investigation, we found 14 different biotypes and 11 antibiotypes among the 45 E. aerogenes isolates, and these typing patterns failed to give
any particular association between the strains. It was evident,
however, that most of the strains were resistant to ampicillin,
co-trimoxazole, aztreonam, ceftazidime, cefazolin, cefuroxime, and
ciprofloxacin. DNA-based techniques have successfully been applied to
demonstrating the differences between E. aerogenes strains
in several studies (7, 11, 12, 13). In this study, we
compared the results of plasmid profiling and PFGE analysis for the
typing of E. aerogenes strains and demonstrated that a
single clone was present over a period of 1 year. Plasmid analysis has
been used most widely as a molecular method for comparing nosocomial
isolates. In our study, the strains were divided into two major
profiles, whereas two strains did not contain any plasmid. Instability
of the plasmid profiles caused by the acquisition or loss of the
plasmids is a great disadvantage of this method. Nevertheless, we found
a good correlation between plasmid profiling and the other DNA-based method that we used, i.e., PFGE. Furthermore, no correlation could be
found between plasmid profiles and antibiotypes (Table 1).
To date, PFGE is the most powerful method for the analysis of
nosocomial isolates because of its high reproducibility and discriminatory power (18, 27). Until now it is recommended as the "gold standard" for defining a clone in various nosocomial bacterial populations. In the present study, we found that almost all
strains were clonal and that 80% of all strains were derived from a
single clone that caused infection or colonization throughout the year.
We evaluated two low-frequency-cleaving enzymes, SpeI and
XbaI, and found that the results obtained with both enzymes were equally reproducible but that the results were more easily interpretable with XbaI-resolved fragments (Fig. 1A and B).
Moreover, use of the XbaI restriction enzyme was more
cost-effective than use of SpeI (about 1/10 the price of
SpeI [GIBCO-BRL]).
Our study emphasizes the value of molecular typing methods for
detecting the clonalities of strains in the investigation of nosocomial
outbreaks caused by E. aerogenes. In conclusion, we found
that plasmid profiling and PFGE with XbaI and/or
SpeI macrorestriction were both useful for the epidemiologic
typing of nosocomial E. aerogenes isolates. In most cases
both techniques provided the same information that differentiated the
unrelated strains and identified nosocomial outbreak-related organisms.
Plasmid profile analysis is faster and requires less expertise than the
PFGE method. It is suggested that it can be used as a screening method,
whereas PFGE is more confirmatory but requires the use of expensive
instruments and more expertise.
 |
ACKNOWLEDGMENTS |
We thank George Zissis for critical review of the manuscript and
Olivier Vandenberg and Van den Abbeele Rudy for providing clinical data
and cooperation during the preparation of the manuscript.
This work was supported in part by grants from the Vesalius
Foundation (foundation for medical research) to Jeanne-Marie Devaster.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, Saint-Pierre University Hospital, Rue Haute 322, B-1000 Brussels, Belgium. Phone: 32-2-535.4530. Fax: 32-2-535.4656. E-mail: jbutzler{at}ben.vub.ac.be.
 |
REFERENCES |
| 1.
|
Arpin, C.,
C. Coze,
A. M. Rogues,
J. P. Gachie,
C. Bebear, and C. Quentin.
1996.
Epidemiological study of an outbreak due to multidrug-resistant Enterobacter aerogenes in a medical intensive care unit.
J. Clin. Microbiol.
34:2163-2169[Abstract].
|
| 2.
| Bio-Rad Laboratories. GenePath Group 3 Reagent
Kit for use with Pseudomonas, Enterobacter.
Catalog no. 310-0004. Bio-Rad Laboratories, Nazareth, Belgium.
|
| 3.
|
Chow, J. W., and D. M. Shlaes.
1991.
Imipenem resistance associated with the loss of a 40 KDa outer membrane protein of Enterobacter aerogenes.
J. Antimicrob. Chemother.
28:499-504[Abstract/Free Full Text].
|
| 4.
|
Davin-Regli, A.,
D. Monnet,
P. Saux,
C. Bosi,
R. Charrel,
A. Barthelemy, and C. Bollet.
1996.
Molecular epidemiology of Enterobacter aerogenes acquisition: one-year prospective study in two intensive care units.
J. Clin. Microbiol.
34:1474-1480[Abstract].
|
| 5.
|
De Champs, C.,
C. Henquell,
D. Guelon,
D. Sirot,
N. Gazuy, and J. Sirot.
1993.
Clinical and bacteriological study of nosocomial infections due to Enterobacter aerogenes resistant to imipenem.
J. Clin. Microbiol.
31:123-127[Abstract/Free Full Text].
|
| 6.
|
De Champs, C.,
D. Guelon,
D. Joyon,
D. Sirot,
M. Chanal, and J. Sirot.
1991.
Treatment of a meningitis due to Enterobacter aerogenes producing a derepressed cephalosporinase and a Klebsiella pneumoniae producing an extended-spectrum beta-lactamase.
Infection
19:181-183[Medline].
|
| 7.
|
De Gheldre, Y.,
N. Maes,
F. Rost,
R. De Ryck,
P. Clevenbergh,
J. L. Vincent, and M. J. Struelens.
1997.
Molecular epidemiology of an outbreak of multidrug-resistant Enterobacter aerogenes infections and in vivo emergence of imipenem resistance.
J. Clin. Microbiol.
35:152-160[Abstract].
|
| 8.
|
Farmer, J. J., III.
1995.
Enterobacteriaceae: introduction and identification, p. 438-449.
In
P. R. Murray, E. J. Baron, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
|
| 9.
|
Garner, J. S.,
W. R. Jarvis,
T. G. Emori,
T. C. Horan, and J. M. Hughes.
1988.
CDC definitions for nosocomial infections.
Am. J. Infect. Control
16:128-140[Medline].
|
| 10.
|
Gaston, M. A.
1988.
Enterobacter: an emerging nosocomial pathogen.
J. Hosp. Infect.
11:197-208[Medline].
|
| 11.
|
Georghiou, P. R.,
R. J. Hamill,
C. E. Wright,
J. Versalovic,
T. Koeuth,
D. A. Watson, and J. R. Lupski.
1995.
Molecular epidemiology of infections due to Enterobacter aerogenes: identification of hospital outbreak-associated strains by molecular techniques.
Clin. Infect. Dis.
20:84-94[Medline].
|
| 12.
|
Grattard, F.,
B. Pozetto,
L. Tabard,
M. Petit,
A. Ros, and O. G. Gaudin.
1995.
Characterization of nosocomial strains of Enterobacter aerogenes by arbitrarily primed PCR analysis and ribotyping.
Infect. Control Hosp. Epidemiol.
16:224-230[Medline].
|
| 13.
|
Grattard, F.,
B. Pozzeto,
P. H. Berthelot,
P. Berthelot,
I. Rayet,
A. Ros,
B. Lauras, and O. G. Gaudin.
1994.
Arbitrarily primed PCR, ribotyping, and plasmid pattern analysis applied to investigation of a nosocomial outbreak due to Enterobacter cloacae in a neonatal intensive care unit.
J. Clin. Microbiol.
32:596-602[Abstract/Free Full Text].
|
| 14.
|
Hopkins, J. M., and K. J. Towner.
1990.
Enhanced resistance to cefotaxime and imipenem associated with outer membrane protein alterations in Enterobacter aerogenes.
J. Antimicrob. Chemother.
25:49-55[Abstract/Free Full Text].
|
| 14a.
|
Jalaluddin, S.,
J.-M. Devaster,
R. Scheen,
M. Gerard, and J.-P. Butzler.
1997.
Molecular epidemiological study of nosocomial infections caused by Enterobacter aerogenes in a Belgian hospital, abstr. L-24, p. 378.
In
Abstracts of the 97th General Meeting of the American Society for Microbiology 1997. American Society for Microbiology, Washington, D.C.
|
| 15.
|
Lambert-Zechovsky, N.,
E. Bingen,
E. Denamur,
N. Brahimi,
P. Brun,
H. Mathieu, and J. Elion.
1992.
Molecular analysis provides evidence for the endogenous origin of bacteremia and meningitis due to Enterobacter cloacae in an infant.
Clin. Infect. Dis.
15:30-32[Medline].
|
| 16.
|
Macrina, F. L.,
D. J. Kopecko,
K. R. Jones,
D. J. Ayers, and S. M. McCowen.
1978.
A multiple plasmid-containing Escherichia coli strain: conventional source of size reference plasmid molecules.
Plasmid
1:417-420[Medline].
|
| 17.
|
Maslow, J., and M. E. Mulligan.
1996.
Epidemiologic typing systems.
Infect. Control Hosp. Epidemiol.
17:595-604[Medline].
|
| 18.
|
Maslow, J. N.,
A. M. Slutsky, and R. D. Arbeit.
1993.
Application of pulsed field gel electrophoresis to molecular epidemiology, p. 563-572.
In
D. H. Persing, T. F. Smith, F. C. Tenover, and T. J. White (ed.), Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Washington, D.C.
|
| 19.
|
Matushek, M. G.,
M. J. M. Bonten, and M. K. Hayden.
1996.
Rapid preparation of bacterial DNA for pulsed-field gel electrophoresis.
J. Clin. Microbiol.
34:2598-2600[Abstract].
|
| 20.
|
Mellencamp, M. A.,
J. S. Roccaforte,
L. C. Preheim,
C. C. Sanders,
C. A. Anene, and M. J. Bittner.
1990.
Isolation of Enterobacter aerogenes susceptible to beta-lactam antibiotics despite high level beta-lactamase production.
Eur. J. Clin. Microbiol. Infect. Dis.
9:827-830[Medline].
|
| 21.
|
Meyers, H. B.,
E. Fontanilla, and L. Mascola.
1988.
Risk factors for development of sepsis in an hospital outbreak of Enterobacter aerogenes.
Am. J. Infect. Control
16:118-122[Medline].
|
| 22.
|
National Committee for Clinical Laboratory Standards.
1997.
Performance standards for antimicrobial disk susceptibility testing, 6th ed. M2A6
National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 23.
|
Neuwirth, C.,
E. Siebor,
J. Lopez,
A. Pechinot, and A. Kazmierzak.
1996.
Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum -lactamase to other members of the family Enterobacteriaceae.
J. Clin. Microbiol.
34:76-79[Abstract].
|
| 24.
|
Peele, D.,
J. Bradfield,
W. Pryor, and S. Vore.
1997.
Comparison of identifications of human and animal source gram-negative bacteria by API 20E and Crystal E/NF systems.
J. Clin. Microbiol.
35:213-216[Abstract].
|
| 25.
|
Pitout, J. D. D.,
E. S. Moland,
C. C. Sanders,
K. S. Thomson, and S. R. Fitzsimmons.
1997.
-Lactamases and detection of -lactam resistance in Enterobacter spp.
Antimicrob. Agents Chemother.
41:35-39[Abstract].
|
| 26.
|
Portnoy, D. A.,
S. L. Moseley, and S. Falkow.
1981.
Characterization of plasmids and plasmid-associated determinants of Yersinia enterocolitica pathogenesis.
Infect. Immun.
31:775-782[Abstract/Free Full Text].
|
| 27.
|
Richard, V. G.
1993.
Molecular epidemiology of nosocomial infection: analysis of chromosomal restriction fragment patterns by pulsed-field gel electrophoresis.
Infect. Control Hosp. Epidemiol.
14:595-600[Medline].
|
| 28.
|
Robinson, A.,
Y. S. McCarter, and J. Tetreault.
1995.
Comparison of crystal enteric/nonfermenter system, API 20E system, and Vitec automicrobic system for identification of gram-negative bacilli.
J. Clin. Microbiol.
33:364-370[Abstract].
|
| 29.
|
Sanders, W. E. J., and C. C. Sanders.
1997.
Enterobacter spp.: pathogens poised to flourish at the turn of the century.
Clin. Microbiol. Rev.
10:220-241[Abstract].
|
| 30.
|
Struelens, M. J.,
F. Rost,
A. Deplano,
A. Maas,
V. Schwam,
E. Serruys, and M. Cremer.
1993.
Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis.
Am. J. Med.
95:489-497[Medline].
|
| 31.
|
Tenover, F. C.,
R. D. Arbeit,
R. V. Goering,
P. A. Mickelsen,
B. E. Murray,
D. H. Persing, and B. Swaminathan.
1995.
Interpreting chromosomal DNA restriction patterns produced by pulsed field gel electrophoresis: criteria for bacterial strain typing.
J. Clin. Microbiol.
33:2233-2239[Medline].
|
| 32.
|
Wauters, G.,
A. Boel,
G. P. Voorn,
J. Verhaegen,
F. Meunier,
M. Janssens, and L. Verbist.
1995.
Evaluation of a new identification system, Crystal Enteric/Non-Fermenter, for gram-negative bacilli.
J. Clin. Microbiol.
33:845-849[Abstract].
|
| 33.
|
World Health Organization.
1981.
Expert Committee on Biological Standardization. Requirements for antibiotic susceptibility tests. Requirements for Biological Substances No. 26.
World Health Organization, Geneva, Switzerland.
|
Journal of Clinical Microbiology, July 1998, p. 1846-1852, Vol. 36, No. 7
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Biendo, M., Canarelli, B., Thomas, D., Rousseau, F., Hamdad, F., Adjide, C., Laurans, G., Eb, F.
(2008). Successive Emergence of Extended-Spectrum {beta}-Lactamase-Producing and Carbapenemase-Producing Enterobacter aerogenes Isolates in a University Hospital. J. Clin. Microbiol.
46: 1037-1044
[Abstract]
[Full Text]
-
Jonas, D., Biehler, K., Hartung, D., Spitzmuller, B., Daschner, F. D.
(2005). Plasmid-Mediated Quinolone Resistance in Isolates Obtained in German Intensive Care Units. Antimicrob. Agents Chemother.
49: 773-775
[Abstract]
[Full Text]
-
Lavigne, J.-P., Bouziges, N., Chanal, C., Mahamat, A., Michaux-Charachon, S., Sotto, A.
(2004). Molecular Epidemiology of Enterobacteriaceae Isolates Producing Extended-Spectrum {beta}-Lactamases in a French Hospital. J. Clin. Microbiol.
42: 3805-3808
[Abstract]
[Full Text]
-
Pournaras, S., Ikonomidis, A., Kristo, I., Tsakris, A., Maniatis, A. N.
(2004). CTX-M enzymes are the most common extended-spectrum {beta}-lactamases among Escherichia coli in a tertiary Greek hospital. J Antimicrob Chemother
54: 574-575
[Full Text]
-
Yigit, H., Anderson, G. J., Biddle, J. W., Steward, C. D., Rasheed, J. K., Valera, L. L., McGowan, J. E. Jr., Tenover, F. C.
(2002). Carbapenem Resistance in a Clinical Isolate of Enterobacter aerogenes Is Associated with Decreased Expression of OmpF and OmpC Porin Analogs. Antimicrob. Agents Chemother.
46: 3817-3822
[Abstract]
[Full Text]
-
Kartali, G., Tzelepi, E., Pournaras, S., Kontopoulou, C., Kontos, F., Sofianou, D., Maniatis, A. N., Tsakris, A.
(2002). Outbreak of Infections Caused by Enterobacter cloacae Producing the Integron-Associated {beta}-Lactamase IBC-1 in a Neonatal Intensive Care Unit of a Greek Hospital. Antimicrob. Agents Chemother.
46: 1577-1580
[Abstract]
[Full Text]
-
Mammeri, H., Laurans, G., Eveillard, M., Castelain, S., Eb, F.
(2001). Coexistence of SHV-4- and TEM-24-Producing Enterobacter aerogenes Strains before a Large Outbreak of TEM-24-Producing Strains in a French Hospital. J. Clin. Microbiol.
39: 2184-2190
[Abstract]
[Full Text]
-
De Gheldre, Y., Struelens, M. J., Glupczynski, Y., De Mol, P., Maes, N., Nonhoff, C., Chetoui, H., Sion, C., Ronveaux, O., Vaneechoutte, M.
(2001). National Epidemiologic Surveys of Enterobacter aerogenes in Belgian Hospitals from 1996 to 1998. J. Clin. Microbiol.
39: 889-896
[Abstract]
[Full Text]
-
Bosi, C., Davin-Regli, A., Bornet, C., Mallea, M., Pages, J.-M., Bollet, C.
(1999). Most Enterobacter aerogenes Strains in France Belong to a Prevalent Clone. J. Clin. Microbiol.
37: 2165-2169
[Abstract]
[Full Text]